Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients. Arru G, Caggiu E, Leoni S, Mameli G, Pugliatti M, Sechi G P, Sechi LA J Neurol Sci. 2015 Jul 8. PMID: 26190523. Abstract CommentRecommendBookmarkWatch